Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells

International Journal of Cancer

Volumn 93, Issue 4, 2001, Pages 507-515

  Dong, Zhong ^a   Nemeth, Jeffrey A ^a,b   Cher, Michael L ^a,b   Palmer, Kenneth C ^a   Bright, Robert C ^b   Fridman, Rafael ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Fibroblast; Matrix metalloproteinase; Prostate cancer; Stroma; Tissue inhibitor of metalloproteinase

Indexed keywords

ANTIBODY; COLLAGEN TYPE 1; ENZYME PRECURSOR; GELATINASE B; GROWTH FACTOR; INTEGRIN; MESSENGER RNA; RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER INVASION; CELL CONTACT; CELL IMMORTALIZATION; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; CELL COMMUNICATION; CHROMATOGRAPHY, GEL; COCULTURE TECHNIQUES; COLLAGENASES; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; ENZYME PRECURSORS; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; INTEGRINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, SCID; PROSTATIC NEOPLASMS; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION;

EID: 0035882579     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1358     Document Type: Article

References (46)

1. Cancer biology: Extracellular proteinases in malignancy
2. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression
3. Matrix metalloproteinases in tumour invasion and metastasis
4. Tissue inhibitors of metalloproteinases: Evolution, structure and function
5. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
6. Cancer statistics, 1999
7. Matrix metalloproteinases and metastasis
8. r 72,000) expression in human prostate: Benign and malignant tissue
9. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer
10. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
11. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
12. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers
13. Expression of metalloproteinase genes in human prostate cancer
14. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia
15. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues
16. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue
17. Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: Analytical aspects
18. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
19. Stromal-epithelial interactions in the normal and neoplastic prostate
20. Genetic and epigenetic influences in prostatic carcinogenesis
21. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens
22. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells
23. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies
24. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Prostate stroma: Physiology
27. Integrins: Versatility, modulation, and signaling in cell adhesion
28. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes
29. Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts
30. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat
31. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes
32. Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma
33. Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: Gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor
34. r 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts
35. Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice
36. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma
37. Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells
38. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells
39. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells
40. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines
41. Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue
42. Activation mechanisms of matrix metalloproteinases
43. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
44. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin
45. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP- 13)
46. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)